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Introduction. Helicobacter pylori (H. pylori) infection is very common worldwide. A reliable diagnosis is crucial for patients with
H. pylori-related diseases. At followup, it is important to conﬁrm that eradication therapy has been successful. There is no
established gold standard for the diagnosis of H. pylori infection. Material and Methods. A sample of 304 volunteers from the
general population was screened for H. pylori infection with serology, 13C-urea breath test (UBT), rapid urease test (RUT) on fresh
biopsy, culture from biopsy, and histological examination. Culture was used as gold standard. Results. The sensitivity was 0.99 for
serology, 0.90 for UBT, 0.90 for RUT, and 0.90 for histological examination. Corresponding speciﬁcities were 0.82, 0.99, 0.98, and
0.97, respectively. The accuracy was 0.86 for serology, 0.96 for UBT, 0.95 for RUT, 0.93 for culture, and 0.95 for histology. There
was a strong correlation between the results of UBT and the histological scores of H. pylori colonisation as well as between the
results of UBT and the scores of RUT. Conclusion. There were only minor diﬀerences in accuracy between the three invasive tests
for H. pylori infection in this population. RUT may be recommended as the ﬁrst choice since a result is obtained within hours. The
accuracy of UBT was comparable to the invasive tests, and it is recommended for situations when endoscopy is not needed.
1.Introduction
Helicobacter pylori (H. pylori) infection is very common
worldwide [1–3]. The infection causes chronic gastritis
which signiﬁcantly increases the risk of developing gastric
or duodenal ulcer, gastric adenocarcinoma, and mucosa-
associated lymphoid tissue (MALT) lymphoma [2, 4].
Recommended indications for H. pylori eradication
therapy are: ulcer disease, MALT lymphoma, atrophic gas-
tritis, post gastric cancer partial resection, maintenance
nonsteroidal anti-inﬂammatory drug treatment (NSAID) or
aspirin ASA), and H. pylori infection in ﬁrst degree relatives
to gastric cancer patients [5, 6]. Bleeding ulcer, sometimes
life threatening, is a common clinical consequence of
H. pylori infection [7, 8]. The incidence of bleeding ulcer
(gastric and duodenal) is almost unchanged since many
years,althoughtherearereportsindicatingthattheincidence
ofduodenalulcerisdeclining[8,9].Consideringthefactthat
the fraction of NSAID- or ASA- (including low dose) related
or idiopathic ulcers has increased, a correct aetiological
diagnosis is mandatory in ulcer disease [10–12]. This further
underlines the necessity of a reliable diagnosis of H. pylori
infection both before and after eradication therapy [13–17].
Noninvasive clinical tests for detection of H. pylori in-
fection are serology (e.g., IgG or IgA antibodies against cell-
surface antigens), 13C-urea breath test (UBT), and faecal
antigen tests [14, 15]. Serology mirrors past (within years) or
current infection. The reported sensitivity and speciﬁcity of
serology measuring IgG antibodies is 80–100% and 69–95%,
respectively [14–16]. Reported sensitivity and speciﬁcity for
UBT is 81–100% and 80–98%, respectively [14–16, 18,
19]. Diﬀerences between studies may in some instances be
explained by diﬀerences in methodology and the choice of
gold standard. In patients with bleeding peptic ulcer the
performance of UBT seems to be superior to biopsy-based
methods and histological examination seems to be superior
to RUT [20].
Invasive tests for diagnosis of H. pylori infection are
the rapid urease test (RUT), histological examination, and2 Gastroenterology Research and Practice
culture of gastric mucosal biopsies. Depending on the choice
of gold standard, the sensitivity and speciﬁcity of RUT is
80–95%and90–100%,respectively,[14–16,18].Histological
examination has a sensitivity of 83–95% and a speciﬁcity
of 90–100%, respectively [15, 16, 18]. For culture, the
reported sensitivity and speciﬁcity is 80–90% and 95–100%,
respectively [15, 16].
Considering the biopsy-based tests, the outcome proba-
bly is inﬂuenced by how many and where biopsies are taken
both in the elective and acute (bleeding) situations [13, 20–
23].
There seems to be no ﬁrm agreement as to which
method should be used as gold standard for the detection of
H. pylori infection. The aim of this study was to determine
the concordance between, and accuracy of, ﬁve diﬀerent
tests for H. pylori infection in a population-based cohort
examined with biopsies from both the antrum and corpus
of the stomach. Culture was used as gold standard.
2.MaterialandMethods
2.1. Study Population. The prevalence and natural history
of chronic gastritis and H. pylori infection in the studied
cohort have been published [24, 25]. The participants were
initially randomly selected from the population register of
the mixed municipality of Link¨ oping, Sweden. In association
with the follow-up study [25], the occurrence of H. pylori
infection was tested with ﬁve diﬀerent methods (serology,
UBT, RUT, culture, and histology) in 304 out of 314
participants. None of the H. pylori infected participants had
receivederadicationtherapy.Tenparticipantshadsubclinical
prepyloric or duodenal ulcer at endoscopic screening [25].
2.2. Endoscopy. The volunteers fasted for at least six hours
before EGD. Blood samples were drawn and EGD car-
ried out after pharyngeal anaesthesia with lidocaine spray
(Xylocaine, AstraZeneca, S¨ odert¨ alje, Sweden). Sedation with
2-3mg intravenous ﬂunitrazepam (Dormicum, Roche AB,
Stockholm, Sweden) was given on demand. Three biopsy
specimens were routinely collected from the gastric body
(major, anterior and posterior aspect) and antrum (within
3cm of the pylorus) for histological classiﬁcation of chronic
gastritis, including grading of H. pylori infection, according
to the revised Sydney system [26]. One additional biopsy
specimen from each of the corpus and antrum was collected
for culture of H. pylori, and further one fresh biopsy from
eachlocationwasanalyzedforH.pyloriwithRUT(CLO-test,
Delta West Pty Ltd, Bently, Australia).
2.3. Diagnostic Tests. Blood samples were stored at −80◦C
until analyzed. Serum IgG antibodies to H. pylori surface
antigens were analyzed by ELISA as previously described,
and results are given as relative optical density (OD), that
is, in percent of positive standards (upper normal limit 5%)
[24, 27].
13CO2-UBT was performed after fasting as in clinical
routine in a VG ISOCHROM-µG mass spectrometer (Fisons,
UK). Breath samples were taken before and 15, 30, 45, and
60min after ingestion of 50mg 13Cu r e a .T h er e s u l tu s e di s
fromthe30-minuteplotonthecurve(deltaoverbaseline30)
with an upper limit of 3.5 per mille. The participants were
fasting and instructedto avoid proton pump inhibitors (PPI)
two weeks before the test. Those in need of PPI, for example,
for gastroesophageal reﬂux disease, were prescribed low dose
H2-blockers during the two weeks preceding UBT.
After orientation, ﬁxation in neutral formaldehyde, and
routine processing of the gastric biopsies, sections cut (5-µm
thick) perpendicular to the surface were stained with hema-
toxylineosin, alcian blue-periodic acid-Schiﬀ,a n dG i e m s a
stain. The histological degree of H. pylori colonisation in
biopsysectionswasscoredasnone,mild,moderate,orsevere
( 0 ,1 ,2 ,3 ) .
The microscopic examinations were performed by an
experienced pathologist without knowledge of other data.
Kappa analysis of blinded repeat evaluation of the degree of
H. pylori colonisation in biopsy sections from the antrum
and corpus in 50 participants (20 without gastritis or
H. pylori infection and 30 with chronic gastritis of whom 22
had H. pylori infection) yielded a Cohen’s Kappa statistic of
0.897 and 0.824, respectively.
Frozen biopsies kept at −80◦C in glycerol contain-
ing freeze medium were defrosted in room temperature,
homogenized, and spread onto H. pylori selective agar
plates (developed at the Microbiology laboratory (LMC),
University Hospital of Link¨ oping, Sweden). One culture
medium was used. This is speciﬁc for H. pylori and contains
GC agar (Acumedia, UK) developed at the accredited Micro-
biologylaboratory(LMC),UniversityHospitalofLink¨ oping,
Sweden. The bacteria were cultured under microaerophilic
conditions at 37◦C and read after 5–7 days. Translucent
colonies typical for H. pylori were recultured and read after
another 5–7 days. After another seven days urease, catalase,
and oxidase tests were done to conﬁrm that the colonies were
H. pylori, all three tests should be positive.
One fresh biopsy was taken from the corpus and antrum
and tested for occurrence of H. pylori with RUT (CLO-test,
Delta West Pty Ltd, Bentley, Australia), which was read after
20min and 1, 3, and 12h (scored 4,3,2,1, resp.). Absence of
H. pylori according to RUT was scored 0.
2.4. Statistics. Agreement between the results of the H. pylori
tests was evaluated by calculating the Cohen’s kappa coeﬃ-
cient. Dichotomized data were used to calculate sensitivity,
speciﬁcity, positive predictive value (PPV), negative predic-
tive value (NPV), and accuracy. The values are given with
95% conﬁdence interval. Each method was tested against
culture as gold standard. The Kruskal-Wallis test was used to
compare results of UBT between the histological scores of H.
pylori colonisation and the scores of RUT, respectively. In all
analyses, a two-sided P value of less than 0.05 was regarded
as signiﬁcant.
3. Results
The median age of the 304 participants of whom 143
were women was 66.1 (45.3–87.9) years. The results ofGastroenterology Research and Practice 3
Table 1: Results of diﬀerent tests for H. pylori infection in population-based cohort of 304 subjects.
Diagnostic method Positive of all tested N
(%)
Corpus and/or antrum,
positive of all tested, N
(%)
Antrum, positive of all
tested N (%)
Corpus, positive of all
tested, N (%)
Serology 119 (39.1) — — —
UBT 91 (29.9) — — —
RUT — 95 (31.3) 88 (28.9) 89 (29.3)
Culture — 101 (33.2) 91 (30.1)a 98 (32.3)b
Histology — 97 (31.9) 86 (28.3) 89 (29.3)
UBT: 13C-urea breath test.
RUT: rapid urease test.

































































Figure 1: Boxplots (showing median and interquartile ranges) of the relation between UBT (per mille) and histological score of H. pylori
colonisation.
the diﬀerent tests for H. pylori infection are presented in
Table 1. Of all 304 participants approximately 1/3 had cur-
rent infection. Table 2 shows the Cohen’s kappa coeﬃcients
for agreement between the diagnostic methods. The best
agreement was between RUT and culture (0.90) and between
UBT and culture (0.91), compartment of the stomach was
disregarded.
Results of comparisons between the diﬀerent tests for
H. pylori infection are presented in Table 3. Considering
the noninvasive tests (Table 3(a)), the UBT showed best
accuracy at 0.96 (0.93–0.98), whereas the corresponding
value for serology was 0.86 (0.82–0.90). Among the invasive
tests, location in the stomach disregarded, accuracy ranged
between 0.93 and 0.95. The invasive tests showed slightly
better accuracy in the antrum than in the corpus.
Relations between the results of UBT and histological
scores of H. pylori colonisation in the corpus and antrum are
illustrated in Figure 1. The two variables were strongly cor-
related considering both the antrum and corpus (P<0.001,
Kruskal-Wallis test). A similar strong correlation for both
the antrum and corpus was present when the results of UBT
were related to the scores of RUT (P<0.001) (Figure 2).
4. Discussion
Areliableprimarydiagnosisandcontroloftreatmentsuccess
of H. pylori infection is crucial for patients with uncom-
plicated or complicated ulcer disease, MALT lymphoma,
atrophicgastritis,previouspartialgastricresectionforgastric
cancer, and probably also for H. pylori infected patients
starting long-term medication with NSAID or low dose ASA
[6, 28].
The aim of this study was to compare the results of
ﬁve diﬀerent H. pylori infection tests in a population-
based cohort. These were serology, UBT, RUT, culture, and
histological examination. Regrettably, stool antigen tests for
H. pylori were not available when subjects were included
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Figure 2:Boxplots(showingmedianandinterquartileranges)ofrelationbetweenRUTscoreandhistologicalscoreofH.pyloricolonisation.
Table 2: Agreement between the results of the tests for H. pylori as
evaluated by the Cohen’s kappa coeﬃcient in study population of
304 subjects.
Test Antrum and/or corpus Antrum Corpus
Serology-UBT 0.77 — —
Serology-RUT 0.77 — —
Serology-culture 0.84 — —
Serology-histology 0.77 — —
UBT-RUT 0.86 — —
UBT-histology 0.83 — —
UBT-culture 0.91 — —
RUT-culture 0.90 0.90a 0.84b
RUT-histology 0.86 0.86 0.84
Culture-histology 0.88 0.82a 0.85b
RUT: rapid urease test, UBT: 13C-urea breath test.
aculture failed in two subjects, bculture failed in one subject.
to Cohen’s kappa analysis was calculated and we used
sensitivity, speciﬁcity, PPV (precision), NPV, and accuracy
to evaluate which combination of the tests may be recom-
mended.
Considering the invasive tests, potential sources of error,
are that too few gastric biopsies, are analyzed and that both
main compartments of the stomach are not represented [13,
17]. In the present study, three biopsies from each location
were analyzed histologically. Although, Warthin-Starry stain
for H. pylori may be more sensitive than giemsa, it is a
cumbersome stain to perform. Moreover, the pathologist
(FP) was used, from clinical practice, to evaluate H. pylori
status based on giemsa stained sections.
According to Cohen’s kappa analysis, the intraexamina-
tor error for histological diagnosis of H. pylori colonisation
was low. RUT and culture, respectively, were performed on
one biopsy from each compartment. Collection of more
than one biopsy from each location for these tests could
potentially have inﬂuenced the results. A potential error in
the UBT is use of PPI prior to testing. The study partic-
ipants were instructed to avoid PPI two weeks before the
examination. Participants on PPI medication, for example,
for gastroesophageal reﬂux disease, were prescribed low dose
H2 blockers during the two weeks preceding UBT.
Agreement between the tests according to Cohen’s kappa
analysis was good (0.91) for culture (compartment of the
stomach disregarded) and UBT. The result was similar for
RUT and culture (0.90). The agreement between the two
latter was betters in the antrum (0.90) than in the corpus
(0.84).
We chose to use accuracy as a measure of the per-
formance of the diagnostic tests. Of the two noninvasive
tests, UBT showed the highest accuracy (0.96 versus 0.86
for serology). Considering the invasive tests, results were
similar; RUT (0.95), culture (0.93), and histology (0.95). The
accuracyoftheinvasivetestswasslightlylower(0.90–0.92)in
thecorpuscomparedwiththeantrum(0.93–0.96).Wefound
no studies reporting accuracy of the diagnostic tests.
In this study, the lowest sensitivity was for UBT (0.89)
and the highest for serology and culture (0.99). Considering
the speciﬁcities, the lowest was for serology (0.82) and the
highest was for UBT (0.99). PPV was lowest for serology
(0.66) and highest for UBT (0.99), whereas NPV only
diﬀered slightly between the tests (0.95–0.99).
In a study by Cutler et al. [14], using several tests
taken together as gold standard, sensitivity, speciﬁcity, PPV,
and NPV were calculated for 13CU B T ,s e r o l o g y ,R U T ,
microscopic occurrence of H. pylori, and chronic and acute
gastritis. Considering the ﬁrstfourtests, diﬀerencesin results
between that study and the present were minor regarding
sensitivitiesandspeciﬁcities,whereasdiﬀerencesweregreaterGastroenterology Research and Practice 5
Table 3: Performance of diﬀerent diagnostic tests for H. pylori infection. Each method is tested against culture as gold standard. RUT: rapid
urease test, UBT = 13C-urea breath test, c.i.: conﬁdence interval.
(a) Antrum and/or corpus. N = 304
Diagnostic test Sensitivity (95% ci.) Speciﬁcity (95% ci.) PPV (95% ci.) NPV (95% ci.) Accuracy (95% ci.)
Serology 0.99 (0.93–1.00) 0.82 (0.76–0.87) 0.66 (0.56–0.74) 0.99 (0.97–1.00) 0.86 (0.82–0.90)
UBT 0.89 (0.81–0.94) 0.99 (0.97–1.00) 0.99 (0.94–1.00) 0.95 (0.91–0.97) 0.96 (0.93–0.98)
RUT 0.90 (0.83–0.95) 0.98 (0.95–0.99) 0.96 (0.90–0.99) 0.95 (0.91–0.98) 0.95 (0.92–0.97)
Histology 0.90 (0.83–0.95) 0.97 (0.94–0.99) 0.94 (0.87–0.98) 0.95 (0.91–0.98) 0.95 (0.92–0.97)
(b) Antrum. N = 302 (culture failed/no growth in two subjects)
Diagnostic test Sensitivity (95% ci.) Speciﬁcity (95% ci.) PPV (95% ci.) NPV (95% ci.) Accuracy (95% ci.)
RUT 0.91 (0.83–0.96) 0.98 (0.95–0.99) 0.95 (0.89–0.99) 0.96 (0.93–0.98) 0.96 (0.93–0.98)
Histology 0.85 (0.76–0.91) 0.96 (0.93–0.98) 0.91 (0.82–0.96) 0.94 (0.89–0.96) 0.93 (0.89–0.95)
(c) Corpus. N = 303 (culture failed/no growth in one subject)
Diagnostic test Sensitivity (95% ci.) Speciﬁcity (95% ci.) PPV (95% ci.) NPV (95% ci.) Accuracy (95% ci.)
RUT 0.94 (0.86–0.98) 0.92 (0.87–0.95) 0.78 (0.68–0.86) 0.98 (0.95–0.99) 0.92 (0.89–0.95)
Histology 0.94 (0.81–0.96) 0.90 (0.85–0.94) 0.74 (0.64–0.83) 0.96 (0.93–0.99) 0.90 (0.86–0.93)
for predictive values, that is, PPVs were lower (UBT 0.99
versus 0.98, RUT 0.96 versus 1.0, serology 0.66 versus 0.95,
and histology 0.94 versus 0.99) and NPVs higher in the
present study. This ﬁnding may be related to diﬀerences
between the studies with regard to the number and location
of biopsies collected and that chronic gastritis was included
among the diagnostic methods in the referred study [14].
Furthermore, there was a diﬀerence in the administered
dose (150mg versus 50mg) of urea and the time interval
(60min versus 30min) until the reading of the UBT.
Another diﬀerence between the studies is that the referred
one concerns patients, whereas the present one concerns a
population-based cohort.
In a study from 2009 by Calvet et al. including 118
patients and using a predeﬁned gold standard (more than
one positive test result), the performance of 13C UBT, RUT,
microscopic examination, and fecal tests was evaluated [18].
The PPVs found in that study were somewhat higher than
those in the present study (RUT 1.0 versus 0.83, histology
0.99 versus 0.81, and UBT 0.92 versus 0.87). These diﬀer-
ences may partly be explained by the fact that only antral
biopsieswereexaminedinthatstudy,whereasbothcompart-
ments of the stomach were examined in the present one.
Average values of sensitivities and speciﬁcities of invasive
and noninvasive tests were calculated in an overview of
epidemiology and diagnosis of H. pylori infection by Logan
and Walker [15]. Our results were within the range of
these average values. The sensitivities and speciﬁcities of
microscopically examination ranged between 88–95% and
90–95%, respectively. Corresponding values for culture were
80–90%, 95–100%, 90–95%, and 90–95% for the urease
test. For serology, the sensitivities were 80–95% and the
speciﬁcities 80–95%. Sensitivities and speciﬁcities for 13C-
UBT ranged between 90–95% and 90–95%, respectively.
Culture was mentioned as the theoretical gold standard.
In a review by Chey and Wong [5], in guidelines of
the American College of Gastroenterology, the urease test
showed sensitivities of more than 90% and speciﬁcities
of more than 95%. Corresponding values for histology
were more than 95% and more than 95%. Considering
serology, sensitivities ranged between 76% and 84% and the
speciﬁcities between 79% and 90%, respectively. For UBT,
both the sensitivities and the speciﬁcities were higher than
95%. Histological examination was used as gold standard.
In conclusion, there were only minor diﬀerences in
accuracy between the three invasive tests for H. pylori infec-
tion in this population. RUT may be recommended as the
ﬁrst choice since a result is obtained within hours. The
accuracy of UBT was comparable to the invasive tests and
it is recommended for situations when endoscopy is not
necessary.
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